Anjali Singh

Drugmaker cites lower contribution from key US products, higher R&D investments and rising operating costs as Q4 FY26 profit declines sharply

GIC and TPG-backed Asia Healthcare Holdings has inducted three independent directors as it expands its specialty healthcare network across India

India's EV industry sees stronger momentum after Prime Minister Narendra Modi renewed his push for electric mobility amid rising sales and infrastructure growth

Bajaj Auto, Hero MotoCorp and Ather Energy flag rising commodity prices, freight costs and supply-chain disruptions as geopolitical tensions weigh on demand and margins

Biocon is scouting for biosimilar in-licensing opportunities while banking on multiple FY27 product launches to drive growth, margins, and market expansion

Bharat Forge reported a 17.5 per cent decline in Q4 net profit due to labour code-related charges and expects around 25 per cent revenue growth in FY27

Mahindra Group has appointed Vimal Agarwal as Group Chief Internal Auditor from July 1, 2026, as the conglomerate sharpens its focus on governance and internal controls

India's electric vehicle market recorded strong annual growth in April 2026, led by a sharp rise in passenger vehicle sales and broader consumer adoption

The rise in profits was attributed to the robust performance in international markets and growth in new launches from Emcure's in-house portfolio

Strained Centre-state relations had long made investors wary, a sentiment reinforced by Trinamool leader Mamata Banerjee's rise on the back of a land agitation in Singur and Nandigram

The company posted a net loss of ₹100.2 crore in Q4 FY26, compared with a loss of ₹234.3 crore in the year-ago period

Aggressive discounting persists in the EV market as automakers juggle inventory, competition, and evolving buyer expectations

Strong growth in hospitals, clinics and labs drives earnings; margins expand on operating leverage and cost discipline across key regional clusters

Castrol India is relying on price hikes and rural expansion to offset rising costs, while sustaining growth through steady demand and market share gains across segments

Piramal Pharma expects a recovery in FY27 with mid-teens revenue growth and improved margins, supported by CDMO rebound, stronger order inflows, and global supply chain shifts

Tyre maker posts strong earnings on international growth and improved mix, but flags near-term margin pressure from rising raw material costs

Castrol India posted steady Q1 FY26 results with higher revenue and profit growth, supported by robust rural and industrial demand, even as it flagged currency volatility & raw material cost pressures

Industry stakeholders believe the move could provide a meaningful boost to India's auto exports, particularly at a time when companies are looking to diversify markets and scale global operations

Pharma veteran Umang Vohra to lead Advent-backed Cohance Lifesciences as chairman and CEO, succeeding Vivek Sharma amid efforts to revive growth and address regulatory challenges

Eight Indian auto brands feature in global top 100, with Mahindra leading at 25th as strong SUV demand, EV push and global expansion drive rising brand value